Human Molecular Genetics Advance Access originally published online on January 20, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, Review Issue 1 R21-R31
DOI: 10.1093/hmg/ddh066
Type 2 diabetes mellitus: not quite exciting enough?
1University Laboratory of Physiology, Parks Road, Oxford OX1 3PT, UK and 2Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford OX3 7LJ, UK
Type 2 diabetes mellitus is a serious metabolic disease that afflicts around 5% of the population in Western societies and over 150 million people worldwide. It is characterized by elevation of the blood glucose concentration, usually presents in middle age, and is exacerbated by obesity. Both genetic and environmental factors contribute to the disease but in the vast majority of cases the aetiology is still not understood. Here we present a novel hypothesis for the aetiology of type 2 diabetes. We postulate that the electrical activity of the insulin-secreting ß-cells of the pancreas acts to integrate the genetic and environmental factors that predispose to disease risk. Our hypothesis is supported by a substantial amount of data gathered from a range of different disciplines and makes predictions that can be tested experimentally both in vitro and in man.
* To whom correspondence should be addressed. Tel: +44 01865285810; Fax: +44 01865285812; Email: frances.ashcroft{at}physiol.ox.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Goldsworthy, A. Hugill, H. Freeman, E. Horner, K. Shimomura, D. Bogani, G. Pieles, V. Mijat, R. Arkell, S. Bhattacharya, et al. Role of the Transcription Factor Sox4 in Insulin Secretion and Impaired Glucose Tolerance Diabetes, August 1, 2008; 57(8): 2234 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Proks, K. Shimomura, T. J. Craig, C. A.J. Girard, and F. M. Ashcroft Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome Hum. Mol. Genet., August 15, 2007; 16(16): 2011 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Tarasov, H. J. Welters, S. Senkel, G. U. Ryffel, A. T. Hattersley, N. G. Morgan, and F. M. Ashcroft A Kir6.2 Mutation Causing Neonatal Diabetes Impairs Electrical Activity and Insulin Secretion From INS-1 {beta}-Cells Diabetes, November 1, 2006; 55(11): 3075 - 3082. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Freeman and R.D. Cox Type-2 diabetes: a cocktail of genetic discovery Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R202 - R209. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gustavsson, G. Larsson-Nyren, and P. Lindstrom Cell specificity of the cytoplasmic Ca2+ response to tolbutamide is impaired in {beta}-cells from hyperglycemic mice. J. Endocrinol., August 1, 2006; 190(2): 461 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Freeman, A. Hugill, N. T. Dear, F. M. Ashcroft, and R. D. Cox Deletion of Nicotinamide Nucleotide Transhydrogenase: A New Quantitive Trait Locus Accounting for Glucose Intolerance in C57BL/6J Mice. Diabetes, July 1, 2006; 55(7): 2153 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimomura, C. A.J. Girard, P. Proks, J. Nazim, J. D. Lippiat, F. Cerutti, R. Lorini, S. Ellard, A. T. Hattersley, F. Barbetti, et al. Mutations at the Same Residue (R50) of Kir6.2 (KCNJ11) That Cause Neonatal Diabetes Produce Different Functional Effects Diabetes, June 1, 2006; 55(6): 1705 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Proks, C. Girard, H. Baevre, P. R. Njolstad, and F. M. Ashcroft Functional Effects of Mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), Causing Neonatal Diabetes, and Response to Sulfonylurea Therapy Diabetes, June 1, 2006; 55(6): 1731 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burdakov, S. M Luckman, and A. Verkhratsky Glucose-sensing neurons of the hypothalamus Phil Trans R Soc B, December 29, 2005; 360(1464): 2227 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Koster, M. A. Permutt, and C. G. Nichols Diabetes and Insulin Secretion: The ATP-Sensitive K+ Channel (KATP) Connection Diabetes, November 1, 2005; 54(11): 3065 - 3072. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Diao, Z. Asghar, C. B. Chan, and M. B. Wheeler Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic {alpha}-Cells J. Biol. Chem., September 30, 2005; 280(39): 33487 - 33496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Proks, C. Girard, and F. M. Ashcroft Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP Hum. Mol. Genet., September 15, 2005; 14(18): 2717 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Hattersley and F. M. Ashcroft Activating Mutations in Kir6.2 and Neonatal Diabetes: New Clinical Syndromes, New Scientific Insights, and New Therapy Diabetes, September 1, 2005; 54(9): 2503 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rorsman Review: Insulin secretion: function and therapy of pancreatic beta-cells in diabetes The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 187 - 191. [Abstract] [PDF] |
||||
![]() |
A. Kuznetsov, V. P. Bindokas, J. D. Marks, and L. H. Philipson FRET-based voltage probes for confocal imaging: membrane potential oscillations throughout pancreatic islets Am J Physiol Cell Physiol, July 1, 2005; 289(1): C224 - C229. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Proks, J. F. Antcliff, J. Lippiat, A. L. Gloyn, A. T. Hattersley, and F. M. Ashcroft Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features PNAS, December 14, 2004; 101(50): 17539 - 17544. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels Diabetes, December 1, 2004; 53(12): 3159 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Campbell, P. Proks, J. D. Lippiat, M. S.P. Sansom, and F. M. Ashcroft Identification of a Functionally Important Negatively Charged Residue Within the Second Catalytic Site of the SUR1 Nucleotide-Binding Domains Diabetes, December 1, 2004; 53(suppl_3): S123 - S127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. McCarthy Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R33 - R41. [Abstract] [Full Text] [PDF] |
||||







